These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37436788)

  • 21. Complement activation in diseases presenting with thrombotic microangiopathy.
    Meri S
    Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Thrombotic microangiopathy : Relevant new aspects for intensive care physicians].
    Gaggl M; Aigner C; Sunder-Plassmann G; Schmidt A
    Med Klin Intensivmed Notfmed; 2016 Jun; 111(5):434-9. PubMed ID: 27255224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis and management of complement mediated thrombotic microangiopathies.
    Cataland SR; Wu HM
    Blood Rev; 2014 Mar; 28(2):67-74. PubMed ID: 24534133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombotic microangiopathy without renal involvement: two novel mutations in complement-regulator genes.
    Peyvandi F; Rossio R; Ferrari B; Lotta LA; Pontiggia S; Ghiringhelli Borsa N; Pizzuti M; Donadelli R; Piras R; Cugno M; Noris M
    J Thromb Haemost; 2016 Feb; 14(2):340-5. PubMed ID: 26613809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atypical Hemolytic Uremic Syndrome Occurring After Receipt of mRNA-1273 COVID-19 Vaccine Booster: A Case Report.
    Claes KJ; Geerts I; Lemahieu W; Wilmer A; Kuypers DRJ; Koshy P; Ombelet S
    Am J Kidney Dis; 2023 Mar; 81(3):364-367. PubMed ID: 36342000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
    Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R
    Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP.
    Cataland SR; Holers VM; Geyer S; Yang S; Wu HM
    Blood; 2014 Jun; 123(24):3733-8. PubMed ID: 24695849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombotic Thrombocytopenic Purpura and Atypical Hemolytic Uremic Syndrome Microangiopathy in Pregnancy.
    Scully M
    Semin Thromb Hemost; 2016 Oct; 42(7):774-779. PubMed ID: 27648610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated Systemic Pentraxin-3 Is Associated With Complement Consumption in the Acute Phase of Thrombotic Microangiopathies.
    Trojnar E; Józsi M; Szabó Z; Réti M; Farkas P; Kelen K; Reusz GS; Szabó AJ; Garam N; Mikes B; Sinkovits G; Mező B; Csuka D; Prohászka Z
    Front Immunol; 2019; 10():240. PubMed ID: 30858847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome.
    Scully M; Goodship T
    Br J Haematol; 2014 Mar; 164(6):759-66. PubMed ID: 24387053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
    Mannucci PM; Cugno M
    Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Syndromes of Thrombotic Microangiopathy.
    Shatzel JJ; Taylor JA
    Med Clin North Am; 2017 Mar; 101(2):395-415. PubMed ID: 28189178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Thrombotic microangiopathies in surgical intensive care medicine with special consideration of atypical hemolytic uremic syndrome].
    Albrecht S; Kamla CE; Schönermarck U; Wassilowsky D
    Anaesthesiologie; 2023 Jan; 72(1):3-12. PubMed ID: 36454255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurological manifestations of thrombotic microangiopathy syndromes in adult patients.
    Weil EL; Rabinstein AA
    J Thromb Thrombolysis; 2021 May; 51(4):1163-1169. PubMed ID: 33755882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
    Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD
    Intern Med J; 2018 Jun; 48(6):624-636. PubMed ID: 29582550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indicators Differentiating Thrombotic Thrombocytopenic Purpura From Other Thrombotic Microangiopathies in a Canadian Apheresis Referral Center.
    Martin SD; McGinnis E; Smith TW
    Am J Clin Pathol; 2021 Nov; 156(6):1103-1112. PubMed ID: 34160013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does severe ADAMTS13 deficiency in thrombotic microangiopathy rule out complement-mediated atypical hemolytic uremic syndrome.
    Arumugam V; Bhowmick R; Agarwal I; Arumadi M
    Saudi J Kidney Dis Transpl; 2019; 30(3):701-705. PubMed ID: 31249236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical hemolytic-uremic syndrome after COVID-19 vaccine: A case report.
    Campos MAG; Ataídes RJC; Ferreira MC; Alves AS; Silva GEB
    Immun Inflamm Dis; 2024 Jul; 12(7):e1270. PubMed ID: 38967360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies: Lessons learned from a 14-year retrospective study.
    Tau J; Fernando LP; Munoz MC; Poh C; Krishnan VV; Dwyre DM
    Ther Apher Dial; 2023 Feb; 27(1):136-145. PubMed ID: 35501999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report.
    Nunius C; Büttner-Herold M; Bertz S; Schiffer M; Buchholz B
    BMC Nephrol; 2020 Mar; 21(1):104. PubMed ID: 32204691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.